Stanford Peng
Overview
Stanford Peng received an average of $1M in total compensation, including $383K in salary, at Nivalis Therapeutics from 2016 to 2021.
2021Nivalis TherapeuticsPresident and Head of Research and Development
2020Nivalis TherapeuticsPresident and Head of Research and Development
2019Nivalis TherapeuticsPresident and Head of Research and Development
2018Nivalis TherapeuticsPresident and Head of Research and Development
2017Nivalis TherapeuticsExecutive Vice President of Research and Development and Chief Medical Officer
2016Nivalis TherapeuticsExecutive Vice President of Research and Development and Chief Medical Officer
Source: SEC filings on April 29, 2022, May 5, 2020, April 24, 2019, and April 24, 2018.
Related executives
We found seven more executives who work or worked at Nivalis Therapeutics.
Mitchell Gold
Nivalis Therapeutics
Chief Executive Officer
Zelanna Goldberg
Nivalis Therapeutics
Chief Medical Officer
Paul Rickey
Nivalis Therapeutics
Chief Financial Officer
Mark Litton
Nivalis Therapeutics
Chief Operating Officer
Janice Troha
Nivalis Therapeutics
Chief Operating Officer
R Carruthers
Nivalis Therapeutics
Chief Financial Officer
Jon Congleton
Nivalis Therapeutics